Dr. Joel Wallach’s Selenium Research Continues to Benefit Many

FDA Now “Urging” Selenium be added to Baby Food Formulas!

SAN DIEGO--()--Youngevity® Essential Life Sciences, a wholly-owned subsidiary of AL International, Inc. (OTC Pink: JCOF), announces that the research of Youngevity® founder, Dr. Joel D. Wallach, BS, DVM, ND, on Selenium continues to be at the forefront of health and prevention with the recent U.S. Food and Drug Administration (FDA) proposed rule requiring the addition of selenium to the list of required nutrients for infant formula products.

Dr. Joel Wallach has been at the front line of Selenium research for nearly 40 years. Selenium is an essential trace mineral that serves many functions in human physiology, including the synthesis of antioxidants (natural substances that neutralize free radical damage), and thyroid and immune function. In 2003, along with Youngevity®, Dr. Wallach successfully petitioned the FDA to establish a Qualified Health Claim for selenium adding that it “may reduce the risk of certain cancers” to labels of dietary supplements containing Selenium.

Dr. Wallach was also the recipient of the Klaus Schwarz Medal in 2011 for his observation done as a researcher at the Yerkes Primate Research Center in Atlanta, Georgia in 1978. Dr. Wallach discovered pancreatic lesions in selenium deficient monkeys identical to those found in human patients discovering the link between selenium deficiencies and some forms of cystic fibrosis; making some forms of cystic fibrosis preventable in humans. This prestigious medal is awarded by the International Association of Bioinorganic Scientists, Inc., honoring trace element researchers for their accomplishments.

Through Dr. Wallach’s research, Youngevity® has been able to provide its distributors with high-quality nutrition products based on his concept that there exist a core group of 90 essential nutrients (which includes selenium) that are necessary for optimal health. Specifically, Youngevity® offers a Healthy Heart & Brain Pak™ that not only contains the 90 essential nutrients, but also Youngevity’s Award Winning Ultimate™ Selenium to help combat free radical damage.

Youngevity CEO, Steve Wallach, said, “My father, Dr. Wallach, has been lecturing on the health benefits of selenium for over 30 years and continues to lecture almost daily, traveling 300 days a year in order to get the message out to the world. It is his belief, and Youngevity’s, that the public is better off by getting the most information available to them in order to come to an educated decision regarding their own health.”

About Dr. Joel Wallach

Before becoming a Naturopathic Physician in 1982, biomedical research pioneer, Dr. Joel D. Wallach, BS, DVM, ND spent two decades in the field of Veterinary Medicine, observing and researching the effects of individual nutrients on animal health. Today, Dr. Wallach is renowned for his groundbreaking research on the health benefits of selenium and other minerals. He currently dedicates his time to lecturing throughout the world on the therapeutic benefits of vitamins and minerals, and on lobbying the U.S. Food and Drug Administration on behalf of the dietary supplement industry.

About Youngevity Essential Life Sciences

Youngevity® Essential Life Sciences (www.youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the Company adopted the name Youngevity in 2006. Youngevity® is the only direct selling company to have a qualified FDA Health Claim. Dr. Wallach's work has been published in more than 70 peer-reviewed and referenced scientific journals and books.

About AL International

AL International, Inc. (OTC Pink: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a "network of networks." The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011.

Safe Harbor Statement

This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.

Contacts

AL International, Inc. - Investor Relations
John Zervas
800-982-3189 X 6509

Sharing

Contacts

AL International, Inc. - Investor Relations
John Zervas
800-982-3189 X 6509